Immunic (IMUX) Interest & Investment Income (2013 - 2026)
Immunic (IMUX) posted Interest & Investment Income of $760000.0 for Q1 2026, up 285.79% sequentially from $197000.0 in Q4 2025, and up 315.3% YoY from $183000.0 in Q1 2025.
Powered by 
Analysis
Immunic (IMUX) Interest & Investment Income (2013 - 2026) Analysis & Trends
Immunic has reported Interest & Investment Income for 14 years, with the latest figure at $760000.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 315.3% year-over-year to $760000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 32.23% YoY) and the FY2025 annual result came in at $1.0 million, down 69.32% from the prior year.
- Interest & Investment Income climbed to $760000.0 in Q1 2026 per IMUX's latest filing, from $197000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.2 million in Q1 2024 and troughed at $7000.0 in Q1 2022.
- A 5-year average of $547411.8 and a median of $541000.0 in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income jumped 11328.57% in 2023, then tumbled 84.58% in 2025.
- Over 5 years, Interest & Investment Income stood at $698000.0 in 2022, then slipped by 22.49% to $541000.0 in 2023, then dropped by 20.7% to $429000.0 in 2024, then tumbled by 54.08% to $197000.0 in 2025, then jumped by 285.79% to $760000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $760000.0, $197000.0, and $419000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Immunic | 538.86 Mn | 538.86 Mn | - | 1.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Mn |
| Mar 31, 2026 | 760,000.00 |
| Dec 31, 2025 | 197,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 241,000.00 |
| Mar 31, 2025 | 183,000.00 |
| Dec 31, 2024 | 429,000.00 |
| Sep 30, 2024 | 776,000.00 |
| Jun 30, 2024 | 998,000.00 |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | 541,000.00 |
| Sep 30, 2023 | 766,000.00 |
| Jun 30, 2023 | 968,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Dec 31, 2022 | 698,000.00 |
| Sep 30, 2022 | 230,000.00 |
| Jun 30, 2022 | 106,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 15,000.00 |
| Sep 30, 2021 | 10,000.00 |